Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

World Orphan Drug Congress 2025 in Amsterdam

Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.

Medscape Education

- PMLiVE

ViiV Healthcare receives NICE recommendation for HIV prevention therapy

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

- PMLiVE

Aqilion announces positive results from eosinophilic esophagitis treatment study

Phase 2 trials for EoE are now expected to be initiated in Europe, Canada and the US

- PMLiVE

Sanofi reports improved patient outcomes from high-dose influenza vaccine

Study data shows a reduced risk of hospitalisation in older adults compared with standard-dose vaccines

- PMLiVE

Mainz Biomed reports on blood-based screening test for pancreatic cancer

The study demonstrated strong clinical accuracy in differentiating pancreatic cancer patients from control subjects

- PMLiVE

Mission Therapeutics advances Parkinson’s disease candidate

The company also received a grant from the Michael J. Fox Foundation and Parkinson’s UK

- PMLiVE

ISPEP launches International Patient Engagement Day 2025

The theme for this year’s global event is ‘Carry the Change’

Intelligent_Commercialization

Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.

Inizio

- PMLiVE

HRW strengthens senior US team with two new Vice Presidents in Manhattan

HRW has announced the appointment of Tina Sallustio and Lauren O’Malley as Vice Presidents in its Manhattan office, reinforcing the agency’s senior leadership team.

Healthcare Research Worldwide

- PMLiVE

Pelage Pharmaceuticals’ alopecia treatment moves forward to phase 3 trial

The news follows positive phase 2a results for the androgenetic alopecia treatment

- PMLiVE

MHRA marks 100 years of patient safety through biological standards

The UK regulator highlights its century-long role in establishing safety and consistency benchmarks

- PMLiVE

Bridging the evidence-to-practice gap in healthcare

By Olivia Atkinson

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links